tm
Seeing Is Believing
tm
Seeing Is Believing
TRVI is currently covered by 2 analysts with an average price target of $9.45. This is a potential upside of $6.59 (230.42%) from yesterday's end of day stock price of $2.86.
Trevi Therapeutics's activity chart (see below) currently has 1 price targets and 11 ratings on display. The stock rating distribution of TRVI is 100% BUY.
Highest price target for TRVI is $8, Lowest price target is $8, average price target is $9.45.
Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 10-Aug-2023. First documented stock forecast 02-Jun-2019.
Currently out of the existing stock ratings of TRVI, 8 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
8
$5.22 (187.77%)
8
8 months 21 days ago
0/7 (0%)
$5.62 (236.13%)
Buy
10
$7.22 (259.71%)
10
1 years 10 months 3 days ago
0/2 (0%)
$7.55 (308.16%)
What is TRVI (Trevi Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on TRVI (Trevi Therapeutics) with a proven track record?
Which analyst has the current lower performing score on TRVI (Trevi Therapeutics) with a proven track record?
Which analyst has the most public recommendations on TRVI (Trevi Therapeutics)?
Which analyst is the currently most bullish on TRVI (Trevi Therapeutics)?
Which analyst is the currently most reserved on TRVI (Trevi Therapeutics)?
